Kang SM - Search Results

1

Jeeva S, Kim KH, Shin CH, Wang BZ, Kang SM. Jeeva S, et al. Among authors: kang sm. Vaccines (Basel). 2021 Aug 29;9(9):965. doi: 10.3390/vaccines9090965. Vaccines (Basel). 2021. PMID: 34579202 Free PMC article. Review.

2

Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.

Wang BZ, Liu W, Kang SM, Alam M, Huang C, Ye L, Sun Y, Li Y, Kothe DL, Pushko P, Dokland T, Haynes BF, Smith G, Hahn BH, Compans RW. Wang BZ, et al. Among authors: kang sm. J Virol. 2007 Oct;81(20):10869-78. doi: 10.1128/JVI.00542-07. Epub 2007 Aug 1. J Virol. 2007. PMID: 17670815 Free PMC article.

3

Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

Wang BZ, Quan FS, Kang SM, Bozja J, Skountzou I, Compans RW. Wang BZ, et al. Among authors: kang sm. J Virol. 2008 Dec;82(23):11813-23. doi: 10.1128/JVI.01076-08. Epub 2008 Sep 10. J Virol. 2008. PMID: 18786995 Free PMC article.

4

Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.

Wang BZ, Xu R, Quan FS, Kang SM, Wang L, Compans RW. Wang BZ, et al. Among authors: kang sm. PLoS One. 2010 Nov 29;5(11):e13972. doi: 10.1371/journal.pone.0013972. PLoS One. 2010. PMID: 21124769 Free PMC article.

5

Influenza virus-like particles containing M2 induce broadly cross protective immunity.

Song JM, Wang BZ, Park KM, Van Rooijen N, Quan FS, Kim MC, Jin HT, Pekosz A, Compans RW, Kang SM. Song JM, et al. Among authors: kang sm. PLoS One. 2011 Jan 18;6(1):e14538. doi: 10.1371/journal.pone.0014538. PLoS One. 2011. PMID: 21267073 Free PMC article.

6

Protective effect of ginseng polysaccharides on influenza viral infection.

Yoo DG, Kim MC, Park MK, Park KM, Quan FS, Song JM, Wee JJ, Wang BZ, Cho YK, Compans RW, Kang SM. Yoo DG, et al. Among authors: kang sm. PLoS One. 2012;7(3):e33678. doi: 10.1371/journal.pone.0033678. Epub 2012 Mar 19. PLoS One. 2012. PMID: 22442708 Free PMC article.

7

Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.

Wang BZ, Gill HS, Kang SM, Wang L, Wang YC, Vassilieva EV, Compans RW. Wang BZ, et al. Among authors: kang sm. Clin Vaccine Immunol. 2012 Aug;19(8):1119-25. doi: 10.1128/CVI.00153-12. Epub 2012 May 30. Clin Vaccine Immunol. 2012. PMID: 22647270 Free PMC article.

8

Microneedle and mucosal delivery of influenza vaccines.

Kang SM, Song JM, Kim YC. Kang SM, et al. Expert Rev Vaccines. 2012 May;11(5):547-60. doi: 10.1586/erv.12.25. Expert Rev Vaccines. 2012. PMID: 22697052 Free PMC article. Review.

9

Virus-like particles as universal influenza vaccines.

Kang SM, Kim MC, Compans RW. Kang SM, et al. Expert Rev Vaccines. 2012 Aug;11(8):995-1007. doi: 10.1586/erv.12.70. Expert Rev Vaccines. 2012. PMID: 23002980 Free PMC article. Review.

10

Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.

Kim MC, Lee JS, Kwon YM, O E, Lee YJ, Choi JG, Wang BZ, Compans RW, Kang SM. Kim MC, et al. Among authors: kang sm. Antiviral Res. 2013 Sep;99(3):328-35. doi: 10.1016/j.antiviral.2013.06.010. Epub 2013 Jun 27. Antiviral Res. 2013. PMID: 23811283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,452 results

Search Page